Major Drug Manufacturer Agrees To Pay $29,600,000 To Patients and States Across US, Settling Allegations of Illegally Inflating Generic Medication Prices
Major Drug Manufacturer Agrees To Pay $29,600,000 To Patients and States Across US, Settling Allegations of Illegally Inflating Generic Medication Prices
Published on
A generic drug company has reached a multi-state settlement, agreeing to pay $29.6 million to patients and states across the US. The settlement resolves allegations of illegally inflating the prices of generic medications and includes cooperation in ongoing investigations.
A generic drug company has agreed to pay millions to settle claims of illegally inflating medication prices. The multistate deal includes cooperation in ongoing investigations.